Login
Toggle sidebar

Lint: interstitial-lung-disease

Acronyms
warning

"anti-SRP autoantibody associated interstitial lung disease"

Line 50:16 · 'SRP' has no definition. Spell it out if it's unfamiliar to the audience.

"cryptogenic organising pneumonia (COP): previously termed BOOP"

Line 71:73 · 'BOOP' has no definition. Spell it out if it's unfamiliar to the audience.

"Antifibrotics are approved for IPF and systemic sclerosis in the USA. Other fibrotic lung diseases only qualify if progression has occurred."

Line 90:69 · 'USA' has no definition. Spell it out if it's unfamiliar to the audience.

"diagnostic HRCT criteria for usual interstitial pneumonia (UIP) pattern - ATS/ERS/JRS/ALAT (2018)"

Line 100:85 · 'ATS' has no definition. Spell it out if it's unfamiliar to the audience.

"diagnostic HRCT criteria for usual interstitial pneumonia (UIP) pattern - ATS/ERS/JRS/ALAT (2018)"

Line 100:89 · 'ERS' has no definition. Spell it out if it's unfamiliar to the audience.

"diagnostic HRCT criteria for usual interstitial pneumonia (UIP) pattern - ATS/ERS/JRS/ALAT (2018)"

Line 100:93 · 'JRS' has no definition. Spell it out if it's unfamiliar to the audience.

"diagnostic HRCT criteria for usual interstitial pneumonia (UIP) pattern - ATS/ERS/JRS/ALAT (2018)"

Line 100:97 · 'ALAT' has no definition. Spell it out if it's unfamiliar to the audience.

"ATS criteria for the diagnosis of UIP on pathology"

Line 102:11 · 'ATS' has no definition. Spell it out if it's unfamiliar to the audience.

"2025 update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement"

Line 104:112 · 'ERS' has no definition. Spell it out if it's unfamiliar to the audience.

"2025 update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement"

Line 104:116 · 'ATS' has no definition. Spell it out if it's unfamiliar to the audience.
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Follow-up"

Line 92:1 · "Follow-up" is not a recognised heading for this article type.
Semicolons
suggestion

"This is the provenance of multi-disciplinary teams; clinical, functional laboratory and CT findings are integrated to reach a consensus diagnosis, if possible. Biopsy is only helpful if it might influence treatment decisions and outcome. Surgical lung biopsy carries significant morbidity and mortality; cryobiopsy is available in some centres."

Line 5:54 · Use semicolons judiciously.

"This is the provenance of multi-disciplinary teams; clinical, functional laboratory and CT findings are integrated to reach a consensus diagnosis, if possible. Biopsy is only helpful if it might influence treatment decisions and outcome. Surgical lung biopsy carries significant morbidity and mortality; cryobiopsy is available in some centres."

Line 5:306 · Use semicolons judiciously.
Links
0
0
0
0
0
0
0
0
0
0
0
0